UroGen Pharma (URGN) Shares Cross Above 200 DMA

In trading on Monday, shares of UroGen Pharma Ltd (URGN) crossed above their 200 day moving average of $26.24, changing hands as high as $26.25 per share. UroGen Pharma Ltd shares are currently trading up about 12.3% on the day..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.